登录

Wellgrow Techonogy Snags $1.4M in Series A Financing, Led by Green Pine Capital Partners

Mailman 2020-01-02 17:49

唯公科技
http://www.wellgrowtec.com/
企业数据由 动脉橙 提供支持
体外诊断医疗设备和试剂研发、生产商 | B+轮 | 运营中
中国-广东
2022-01-25
融资金额:数亿人民币
招商健康战略
查看

According to lieyunwang.com, in-vitro diagnostic (IVD) reagent and medical device developer Shenzhen Wellgrow Techonogy Co., Ltd. ("Wellgrow Techonogy") has completed the Series A Financing of tens of millions yuan (US$1.4 million), led by Green Pine Capital Partners with participation from Vinno Capital. Proceeds of this financing will be used for the R&D of the FCM (flow cytometry method) immunoassay platform and relevant products, which is expected to achieve lower cost and high flux in the field of IVD clinical immunoassay.


Founded in August 2016, Wellgrow Techonogy focuses on the R&D of in-vitro diagnostic reagents and medical devices. The company is committed to the development of fluorescence detection technology. Its product includes cell analysis and detection equipment, such as flow cytometers, which can be used in life science research, clinical diagnosis and food safety testing, etc.


The members of Wellgrow Techonogy's R&D team have experience in IVD product development for 15 years on average. At present, the encoding microbeads based on the EasyCell FCM platform of Wellgrow Techonogy is fully compatible with the mainstream flow cytometers and has been able to support the development of up to 30 co-detection reagents.


>>>>
About Green Pine Capital Partners 


Founded in 2007, Green Pine Capital Partners is one of the most time-honored venture capital institutions in China, with rich experience in biomedicine, new energy and materials, advanced manufacturing, artificial intelligence, and other fields. The company not only provides funds for the invested enterprises, but also provides high-quality post-investment services and integrated resources. Green Pine Capital Partners manages funds of ten billion yuan and has invested more than 7 billion yuan.


>>>>

About Vinno Capital


Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields. The company looks for cutting-edge technologies mainly in China, North America and Israel.

相关赛道 IVD
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。
推荐阅读

妇女获得医疗保健的10个最佳和最差州

Becker's Hospital Review 2024-07-23 02:50

HSS佛罗里达任命首席医疗官

Becker's Hospital Review 2024-07-23 02:49

MetroHealth推出助产服务

Becker's Hospital Review 2024-07-23 02:49

Mailman

共发表文章3245篇

最近内容
查看更多
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

相关公司
查看更多

唯公科技

体外诊断医疗设备和试剂研发、生产商

立即沟通

合创资本

早期风险投资机构

立即沟通

松禾资本

创业投资管理机构

立即沟通
产业链接
查看更多